461 related articles for article (PubMed ID: 7904317)
1. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.
Schechter M; Harrison LH; Halsey NA; Trade G; Santino M; Moulton LH; Quinn TC
JAMA; 1994 Feb; 271(5):353-7. PubMed ID: 7904317
[TBL] [Abstract][Full Text] [Related]
2. Performance of absolute CD4+ count in predicting co-infection with human T-lymphotropic virus type 1 in antiretroviral-naive HIV-infected patients.
Gudo ES; Bhatt NB; Augusto O; Semá C; Savino W; Ferreira OC; Jani IV
Int J STD AIDS; 2012 Oct; 23(10):717-23. PubMed ID: 23104746
[TBL] [Abstract][Full Text] [Related]
3. Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients.
Bhatt NB; Gudo ES; Semá C; Bila D; Di Mattei P; Augusto O; Garsia R; Jani IV
Int J STD AIDS; 2009 Dec; 20(12):863-8. PubMed ID: 19948902
[TBL] [Abstract][Full Text] [Related]
4. HIV viral load and CD4+ lymphocyte counts in subjects coinfected with HTLV-I and HIV-1.
Schechter M; Moulton LH; Harrison LH
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Aug; 15(4):308-11. PubMed ID: 9292591
[TBL] [Abstract][Full Text] [Related]
5. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression.
Brites C; Sampalo J; Oliveira A
AIDS Rev; 2009; 11(1):8-16. PubMed ID: 19290030
[TBL] [Abstract][Full Text] [Related]
6. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.
Beilke MA; Traina-Dorge VL; Sirois M; Bhuiyan A; Murphy EL; Walls JM; Fagan R; Winsor EL; Kissinger PJ
Clin Infect Dis; 2007 May; 44(9):1229-34. PubMed ID: 17407044
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2.
Beilke MA; Theall KP; O'Brien M; Clayton JL; Benjamin SM; Winsor EL; Kissinger PJ
Clin Infect Dis; 2004 Jul; 39(2):256-63. PubMed ID: 15307036
[TBL] [Abstract][Full Text] [Related]
8. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
Casoli C; Pilotti E; Bertazzoni U
AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
[TBL] [Abstract][Full Text] [Related]
9. Human T-lymphotropic virus/HIV co-infection: a clinical review.
Dhasmana D; Taylor GP
Curr Opin Infect Dis; 2014 Feb; 27(1):16-28. PubMed ID: 24305042
[TBL] [Abstract][Full Text] [Related]
10. Human T lymphotropic virus 1 and hepatitis C virus as risk factors for inflammatory dermatoses in HIV-positive patients.
Bonamigo RR; Borges K; Rietjens J; Arenzon S; Blanco LF; Loureiro R
Int J Dermatol; 2004 Aug; 43(8):568-70. PubMed ID: 15304178
[TBL] [Abstract][Full Text] [Related]
11. Coinfection with HTLV-I and HIV: increase in HTLV-I-related outcomes but not accelerated HIV disease progression?
Harrison LH; Schechter M
AIDS Patient Care STDS; 1998 Aug; 12(8):619-23. PubMed ID: 15468433
[TBL] [Abstract][Full Text] [Related]
12. Immune Compromise in HIV-1/HTLV-1 Coinfection With Paradoxical Resolution of CD4 Lymphocytosis During Antiretroviral Therapy: A Case Report.
Rockwood N; Cook L; Kagdi H; Basnayake S; Bangham CRM; Pozniak AL; Taylor GP
Medicine (Baltimore); 2015 Dec; 94(50):e2275. PubMed ID: 26683952
[TBL] [Abstract][Full Text] [Related]
13. Immunohaematological findings in healthy and HIV-1 infected adults in Dar es Salaam, Tanzania.
Urassa WK; Lyamuya EF; Mbena E; Kagoma C; Bredberg Raden U; Pallangyo KP; Magessa P; Mhalu FS; Biberfeld G
East Afr Med J; 1996 Oct; 73(10):670-4. PubMed ID: 8997848
[TBL] [Abstract][Full Text] [Related]
14. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
16. Surrogate markers of disease progression in HIV-infected children in Rio de Janeiro, Brazil.
Ortigão-de-Sampaio MB; Abreu TF; Linhares-de-Carvalho MI; Ponce de Leon A; Castello-Branco LR
J Trop Pediatr; 1999 Oct; 45(5):299-302. PubMed ID: 10584474
[TBL] [Abstract][Full Text] [Related]
17. Higher mortality in HIV-2/HTLV-1 co-infected patients with pulmonary tuberculosis in Guinea-Bissau, West Africa, compared to HIV-2-positive HTLV-1-negative patients.
Norrgren H; Bamba S; Da Silva ZJ; Koivula T; Andersson S
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e142-7. PubMed ID: 20395161
[TBL] [Abstract][Full Text] [Related]
18. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
[TBL] [Abstract][Full Text] [Related]
19. High levels of CC-chemokine expression and downregulated levels of CCR5 during HIV-1/HTLV-1 and HIV-1/HTLV-2 coinfections.
Oo Z; Barrios CS; Castillo L; Beilke MA
J Med Virol; 2015 May; 87(5):790-7. PubMed ID: 25678365
[TBL] [Abstract][Full Text] [Related]
20. Myelopathy among Brazilians coinfected with human T-cell lymphotropic virus type I and HIV.
Harrison LH; Vaz B; Taveira DM; Quinn TC; Gibbs CJ; de Souza SH; McArthur JC; Schechter M
Neurology; 1997 Jan; 48(1):13-8. PubMed ID: 9008486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
